Volitionrx (VNRX) EBITDA Margin (2012 - 2025)
Volitionrx (VNRX) reported EBITDA Margin of 163775.29% for Q4 2025, up 14839230.0% on a YoY basis from N/an in Q4 2024, and up 16466.48% quarter-over-quarter from 1000.67% in Q3 2025.
Volitionrx (VNRX) EBITDA Margin (2012 - 2025) Analysis & Trends
Volitionrx has reported EBITDA Margin for 8 years, with the latest figure at 163775.29% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin rose 14839230.0% year-over-year to 163775.29%; the trailing twelve-month figure through Dec 2025 stood at 2036.24% (up 85793.0% YoY), and the FY2025 full-year result was 1894.44%, up 80270.0% from the prior year.
- EBITDA Margin for Q4 2025 stood at 163775.29%, up from 1000.67% in the prior quarter.
- The five-year high for EBITDA Margin was 163775.29% in Q4 2025, with the low at 61692.56% in Q4 2021.
- Historically, EBITDA Margin has averaged 2388.21% across 5 years, with a median of 5013.92% in 2023.
- Annual changes were most pronounced in 2021 — EBITDA Margin surged 190771026 bps — and 2025, when it surged 8378 bps.
- Volitionrx's EBITDA Margin stood at 61692.56% in 2021, then soared by 90 bps to 6201.93% in 2022, then soared by 42 bps to 3605.06% in 2023, then jumped by 527 bps to 15382.99% in 2024, then soared by 965 bps to 163775.29% in 2025.
- The last three EBITDA Margin figures came in at 163775.29% (Q4 2025), 1000.67% (Q3 2025), and 1694.19% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Volitionrx | 53.00 Mn | 50.54 Mn | -1.01 Mn | 163,775.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 163,775.29% |
| Sep 30, 2025 | -1,000.67% |
| Jun 30, 2025 | -1,694.19% |
| Mar 31, 2025 | -2,325.85% |
| Dec 31, 2024 | 15,382.99% |
| Sep 30, 2024 | -1,480.11% |
| Jun 30, 2024 | -1,777.97% |
| Mar 31, 2024 | -4,930.18% |
| Dec 31, 2023 | -3,605.06% |
| Sep 30, 2023 | -5,097.66% |
| Jun 30, 2023 | -4,398.12% |
| Mar 31, 2023 | -5,960.55% |
| Dec 31, 2022 | -6,201.93% |
| Sep 30, 2022 | -23,663.40% |
| Jun 30, 2022 | -18,912.02% |
| Mar 31, 2022 | -6,860.91% |
| Dec 31, 2021 | -61,692.56% |
| Sep 30, 2021 | -29,675.83% |
| Jun 30, 2021 | -23,810.25% |
| Mar 31, 2021 | -23,835.14% |